Dinno Mendiola

University of Miami

Papers

1

Total Citations

10

H-Index

1

About

Dr. Dinno Mendiola is a leading urologic oncologist whose research centers on advancing minimally invasive, kidney-sparing surgical techniques for upper urinary tract urothelial carcinoma. His most impactful work stems from the ROBUUST 2.0 collaborative group, where he led a pivotal multicenter comparative analysis demonstrating that robot-assisted distal ureterectomy can achieve excellent oncological control while preserving renal function in patients with high-risk distal ureteral tumors—a population traditionally managed with radical nephroureterectomy. This 2024 study, already garnering 10 citations, challenges established treatment paradigms by showing that kidney-sparing surgery is both feasible and oncologically sound for select high-risk cases. Dr. Mendiola’s contributions are reshaping clinical decision-making, offering patients a chance to avoid the morbidity of complete kidney removal without compromising cancer outcomes. His work sits at the intersection of surgical innovation and evidence-based urology, providing robust data that empowers surgeons to expand indications for nephron-sparing approaches. For trainees and researchers, Dr. Mendiola exemplifies how rigorous multicenter collaboration can translate complex surgical questions into practice-changing answers, making him a key voice in the evolution of robotic urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 36
🏛 Institutions: University of Miami

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago